// App-Quantinova.ai

522 : Liquid biopsy for diagnosis in patients with suspected pancreatic and biliary tract cancers: PREVAIL ctDNA pilot trial.

Researchers

Presenter

  • Justin Mencel

Principal Investigators

  • Ruwaida Begum

  • Paul Carter

  • Michaela Smalley

  • Elli Bourmpaki

  • Josh Shur

  • Sameer Zar

  • Darina Kohoutova

  • Sanjay Popat

  • Angela George

  • Terri Patricia McVeigh

  • Michael Hubank

  • Clare Peckitt

  • Charlotte Victoria Fribbens

  • David J. Watkins

  • Sheela Rao

  • Ian Chau

  • David Cunningham

  • Naureen Starling

Medical Centers

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Institute of Cancer Research, Sutton, United Kingdom

  • Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Advanced biliary tract carcinoma

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

  • Cohort

  • Single Center

Phase

  • N/A

Study Id's

  • NCT04566614

Sponsors

  • N/A

Result

  • N/A